Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

European Innovation Council · Running

V-LF-Spiro3D Low and very-low-field 3D magnetic resonance spirometry for advanced regional exploration of respiratory diseases

Coordinator
Universite Paris-Saclay, France
Runs
1 April 2023 to 31 March 2027
Status
Running
EU funding
€3.6m
Total cost
€3.6m
Partners
16 organisations in 4 countries
Type
European Innovation Council
Grant agreement
101099934

What the project is doing

In the project's own words, from its summary on CORDIS.

Lung function is a central concern in the fight against covid-19. Beyond the pandemic heavy losses and long-term health implications, respiratory diseases represent a major threat for the World Health Organisation. It is one of the leading causes of death worldwide, associated to our way of living and impacting all of society. Current tools for diagnosing and monitoring pulmonary conditions are hindered by poor sensitivity (lung function tests), radiation exposure (computed tomography) or examination cost (magnetic resonance imaging, MRI).

They all differently fail to fully assess lung structure and functionV|LF-Spiro3D aims at democratizing newly developed and breakthrough 3D MR spirometry with high performance, low-cost MRI techniques to provide a ten-minute morphofunctional MRI protocol to engage patients in a safer, easier and more comfortable way. Based on recent works at Universities Paris-Saclay and Aberdeen, in collaboration with leading MR manufacturer Siemens, SME NMR Service, major French-Dutch hospitals and patient organisations, V|LF-Spiro3D brings together multidisciplinary experts in a patient-oriented approach for both adults and childrenV|LF-Spiro3D will redesign current MRI architecture to perform 3D MR spirometry at low and very low field.

High-performance MRI hardware will be developed with accelerated acquisitions and coupled reconstruction strategies relying on deep learning. Biomechanical lung modelling and deep data processing will be guided by implementation of 3D MR spirometry in clinical facilities to produce unprecedentedly large sets of normative and training data covering six major respiratory diseasesBy prioritizing both technology transfer and innovation, V|LF-Spiro3D aims to build up a one-stop-shop imaging standard for unrestricted assessment of lung pathophysiology.

The impacts are expected to yield benefits beyond lung imaging and boost health deep-tech on point-of-care imaging and multi-parameter-based digital health in the EU

Who is involved

OrganisationCityCountryRole
Universite Paris-SaclayGif-Sur-YvetteFranceCoordinator
Nmr Service GmbHErfurtGermanyParticipant
Assistance Publique Hopitaux De ParisParisFranceParticipant
Association Hopital FochSuresnes CedexFranceParticipant
Centre National De La Recherche Scientifique CNRSParisFranceThird party
Commissariat a L Energie Atomique Et Aux Energies AlternativesParisFranceThird party
Ecole PolytechniquePalaiseau CedexFranceThird party
Institut Mines-TelecomPalaiseauFranceThird party
Institut National De La Sante Et De La Recherche MedicaleParisFranceThird party
Institut National De Recherche En Informatique Et AutomatiqueLe Chesnay CedexFranceThird party
Institut Polytechnique De ParisPalaiseauFranceParticipant
Pole De Ressources En Education Therapeutique Du Patient Ile De FranceParisFranceParticipant
Siemens Healthcare SASCourbevoieFranceParticipant
Erasmus Universitair Medisch Centrum RotterdamRotterdamNetherlandsParticipant
Tilburg University- Universiteit Van TilburgTilburgNetherlandsParticipant
The University Court of the University of AberdeenAberdeenUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI